Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa

Scientific Reports
David A DonkorWilliam P Sheffield

Abstract

Factor XIa (FXIa) is a serine protease that catalyzes the activation of Factor IX (FIX) in the blood coagulation cascade. FXIa and its precursor FXI are emergent therapeutic targets for the development of safer anticoagulant agents. Here, we sought a novel DNA-based agent to inhibit FXIa. Towards this goal, an 80 base, single-stranded DNA aptamer library (containing a 40 base randomized core) was screened for FXIa-binding candidates, using ten rounds of positive and negative selection. After selection, 6 of 89 different sequences inhibited FXIa-mediated chromogenic substrate S2366 cleavage. The most active anti-FXIa aptamer had a hypervariable central sequence 5'-AACCTATCGGACTATTGTTAGTGATTTTTATAGTGT-3' and was designated Factor ELeven Inhibitory APtamer (FELIAP). FELIAP, but not a scrambled aptamer control (SCRAPT), competitively inhibited FXIa-catalyzed S2366 cleavage, FIX activation, and complex formation with antithrombin. No effect of FELIAP on FXI activation was observed. FELIAP inhibited plasma clotting and thrombin generation assays to a significantly greater extent than SCRAPT. Immobilized FELIAP bound FXIa with strong affinity and an equilibrium binding constant (KD) in the low nanomolar range determined using surface ...Continue Reading

References

Jun 27, 1991·The New England Journal of Medicine·J Hirsh
Nov 22, 1997·Journal of Molecular Biology·D M TassetW Steiner
Mar 9, 2000·The New England Journal of Medicine·J C MeijersF R Rosendaal
Sep 14, 2001·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·W P SheffieldV Bhakta
Sep 6, 2002·Nature·Christopher P RusconiBruce A Sullenger
Jun 26, 2003·Nucleic Acids Research·Michael Zuker
Aug 4, 2004·British Journal of Haematology·William P SheffieldFrederick A Ofosu
Oct 27, 2004·Nature Biotechnology·Christopher P RusconiBruce A Sullenger
Jul 13, 2005·The Journal of Experimental Medicine·Thomas RennéBernhard Nieswandt
Aug 30, 2008·The New England Journal of Medicine·Bruce Furie, Barbara C Furie
Dec 22, 2009·The Journal of Biological Chemistry·Sai K BuddaiSriram Krishnaswamy
Jan 30, 2010·Blood·Jonas EmsleyDavid Gailani
Dec 2, 2010·Toxicologic Pathology·Andrew J Gale
Jul 7, 2011·Current Opinion in Hematology·Felicitas MüllerThomas Renné
Feb 16, 2012·The Journal of Biological Chemistry·Bruce SullengerDougald M Monroe
Apr 17, 2012·Journal of Thrombosis and Haemostasis : JTH·J P VavalleR C Becker
Jul 4, 2012·The Journal of Clinical Investigation·Nigel Mackman
May 23, 2013·Journal of Thrombosis and Haemostasis : JTH·R S WoodruffB A Sullenger
Dec 9, 2014·The New England Journal of Medicine·Harry R BüllerUNKNOWN FXI-ASO TKA Investigators
Mar 21, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Calvin H YehJeffrey I Weitz
Jun 20, 2015·Scientific Reports·Rachel GysbersYingfu Li
Apr 26, 2016·Methods : a Companion to Methods in Enzymology·Yi Xi Wu, Young Jik Kwon
May 22, 2016·Thrombosis Research·Jeffrey I Weitz

❮ Previous
Next ❯

Citations

Jul 18, 2018·Current Opinion in Hematology·Charlene V ChabataRuwan Gunaratne
Dec 23, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeffrey I Weitz, James C Fredenburgh
Dec 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Jeffrey I Weitz, Noel C Chan
Feb 1, 2019·Circulation Research·Noel C Chan, Jeffrey I Weitz
Dec 19, 2019·Expert Opinion on Therapeutic Patents·Rami A Al-Horani
Nov 23, 2019·Brain : a Journal of Neurology·Eric L HarshfieldHugh S Markus
Aug 3, 2020·Current Opinion in Hematology·Priyanka Srivastava, David Gailani
May 5, 2018·Medicinal Research Reviews·Rami A Al-Horani, Daniel K Afosah
Oct 24, 2020·Chembiochem : a European Journal of Chemical Biology·Siriluk RatanabunyongSupa Hannongbua
Nov 19, 2020·ChemistryOpen·Srabani KarRami A Al-Horani
Aug 5, 2018·Blood Reviews·Benjamin F TillmanDavid Gailani
May 1, 2021·International Journal of Molecular Sciences·Max LiuYolanda M Fortenberry
Jun 8, 2021·Nucleic Acids Research·Kaori TsukakoshiKazunori Ikebukuro
Apr 19, 2018·The Journal of Organic Chemistry·Hoan Q Duong, Scott McN Sieburth
May 19, 2018·Journal of Medicinal Chemistry·Mimi L QuanRuth R Wexler

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Surface
chip
SELEX
electrophoresis
Assay
chips

Software Mentioned

Excel
FELIAP
Basespace
Mfold

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.